Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00743262 · FLOW

Participant flow

Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis · Source last updated 2023-07-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    A group of laryngectomized Provox ActiValve users tested the Provox Vega 22.5 French voice prosthesis for 3 weeks.
    id
    FG000
    title
    Provox Vega 22.5 French
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        15
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        15
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    A group of laryngectomized Provox ActiValve users tested the Provox Vega 22.5 French voice prosthesis for 3 weeks.
    id
    FG000
    title
    Provox Vega 22.5 French
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        15
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        15
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice